Back to search

Georgia Institute of Technology

Engineering Multivalent Viral Vaccines

Abstract

dc:description.abstract

The ability to design efficacious vaccines for many diseases has been hindered by existing sequence diversity in pathogen proteins and by newly-acquired mutations that enable escape from adaptive immune responses. To address these limitations, we have developed an approach for nanopatterning protein antigens to focus the immune response on conserved protein regions. This approach combines the site-specific incorporation of non-canonical amino acids into proteins with chemical modification with polyethylene glycol (PEG) or other molecules. We will describe the design of a ZIKV vaccine based on domain III (DIII) of the viral envelope protein (E). By chemically modifying the protein surface, we have demonstrated the ability to refocus the immune response to targeted epitopes on the protein antigen. We also demonstrate the ability to enhance immunogenicity by the multivalent presentation of nanopatterned antigens on scaffolds. Also in the context of the Zika virus vaccines, it would be advantageous to design a vaccine that promotes the generation of broadly neutralizing antibodies. A promising epitope to target is the Envelope Dimer Epitope (EDE), located at the interface between two E proteins in a dimer, that is highly conserved among Zika and Dengue viruses. To achieve this goal, we will demonstrate an approach that we have developed for stabilizing E dimers on the surface of virus-like particles (VLPs). Finally, in response to the current pandemic, we will describe the design of vaccines presenting the Receptor Binding Domain (RBD) of the Spike protein of the novel SARS-CoV-2 virus. Furthermore, we will test the ability to use glycans to shield different epitopes on RBD. This approach could be used to design vaccines that generate a more potent SARS-CoV-2-specific neutralizing antibody response, as well as those that can confer protection against both SARS-CoV and SARS-CoV-2.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Chemical and Biomolecular Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Stringari De Castro, Ana Luisa
Advisor dc:contributor.advisor
  • Kane, Ravi S.
Committee members dc:contributor.committeemember
  • Champion, Julie
  • Paravastu, Anant
  • Platt, Manu O
  • Prausnitz, Mark

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1853/66043

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Stringari De Castro, Ana Luisa. Engineering Multivalent Viral Vaccines. Doctoral thesis, Georgia Institute of Technology, 2021. http://hdl.handle.net/1853/66043